K214049: Leaseir MHR Xcell (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K214049 (Leaseir MHR Xcell, cleared 2022-06-02 for Leaseir Technologies, Slu) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K214049
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK214049
Cleared Device Trade / Generic NameLeaseir MHR Xcell
FDA Applicant on FilingLeaseir Technologies, Slu
FDA 3-Letter Product ClassificationProduct Code GEX
FDA Substantial Equivalence Decision Date2022-06-02
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Inspect consolidated manufacturer lineage at Leaseir Technologies, Slu, compare peer devices under FDA Product Code GEX, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.